Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
All women underwent testing for factor V Leiden mutation (FVL), mutation of the coagulation factors II (FII20210), methylenetetrahydrofolate reductase (MTHFR), plasminogen activator inhibitor-1, antithrombin III (ATIII), protein C (PC) and protein S, lupus anticoagulant (LAC) antibodies, anticardiolipin antibodies and anti-beta-2-glycoprotein-1.
|
25586317 |
2016 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
These included screening coagulations tests, tests for lupus anticoagulant (LA), IgG and IgM antibodies to anticardiolipin antibodies (ACA), beta2 glycoprotein 1 (beta2GP1) and annexin V. The genetic markers studied included protein C (PC), protein 5 (PS), antithrombin III (AT III), factor V Leiden (FVL), PT gene G20210A, MTHFR C677T, EPCR 23 bp insertion and PAI 4G/5G polymorphisms.
|
19004141 |
2009 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
All women were tested for the presence of inherited [factor V Leiden (FVL) mutation, prothrombin mutation, methylenetetrahydrofolate reductase (MTHFR) mutation and deficiencies in proteins S and C and antithrombin III] or acquired (lupus anticoagulant and anticardiolipin) thrombophilic factors.
|
16835215 |
2006 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
We found 22 (48%) patients with the SPS, 11 (24%) with the aPCR phenotype, 5 (11%) with the factor V Leiden mutation, 7 (15%) with the prothrombin gene mutation, 29 (63%) with the MTHFR gene mutation, 11 (24%) with the factor V HR2 haplotype, 11 (24%) with antiphospholipid antibodies, 4 (9%) with PS deficiency, 6 (13%) with PC deficiency, one with the FV Hong Kong mutation, and one with AT-III deficiency.
|
15609280 |
2005 |
Factor V Leiden mutation
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
A member of this family carrying this mutation was also found to be heterozygotic for the MTHFR mutation, factor V Leiden mutation and had low serum levels of antithrombin III, thus resulting in the appearance of recurrent strokes and thrombotic episodes since his early adulthood.
|
16193256 |
2005 |
Factor V Leiden mutation
|
0.090 |
AlteredExpression
|
disease |
BEFREE |
The following laboratory tests were performed: prothrombin time, partial thromboplastin time, fibrinogen levels, antithrombin III, plasmatic fibronectin (as a marker of endothelial damage), haptoglobin (as a marker of intravascular haemolysis), a functional test for APC-R and analysis of factor V Leiden mutation by polymerase chain reaction.
|
12571435 |
2002 |
Factor V Leiden mutation
|
0.090 |
Biomarker
|
disease |
BEFREE |
Our data do not suggest that thrombotic diatheses due to deficiency of protein C, protein S, or antithrombin III or due to factor-V Leiden mutation are major causes of Legg-Perthes disease.
|
12208918 |
2002 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
Determinations in blood samples of homocysteine concentrations; the occurrence of 677 C-->T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene; protein C activities; activated protein C resistance ratios; concentrations of free protein S antigen; antithrombin III activities; and the occurrence of factor V Leiden mutation.
|
10847236 |
2000 |
Factor V Leiden mutation
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
We studied the prevalence of antithrombin III (AT III), protein C (PC) and protein S (PS) deficiencies and factor V Leiden mutation in thrombophilia in Taiwan.
|
9271815 |
1997 |